BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11899767)

  • 1. Chronic myelogenous leukemia: an overview.
    Tennant L
    Clin J Oncol Nurs; 2001; 5(5):218-9. PubMed ID: 11899767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia.
    Giles FJ; DeAngelo DJ; Baccarani M; Deininger M; Guilhot F; Hughes T; Mauro M; Radich J; Ottmann O; Cortes J
    Semin Oncol; 2008 Feb; 35(1 Suppl 1):S1-17; quiz S18-20. PubMed ID: 18346528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for newly diagnosed patients with chronic myeloid leukemia.
    Maness LJ; McSweeney PA
    Curr Hematol Rep; 2004 Jan; 3(1):54-61. PubMed ID: 14695851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction: chronic myelogenous leukemia leading advanced clinical oncology].
    Asano S
    Nihon Rinsho; 2001 Dec; 59(12):2309-10. PubMed ID: 11766330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspective.
    Maziarz RT; Mauro MJ
    Bone Marrow Transplant; 2003 Sep; 32(5):459-69. PubMed ID: 12942091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors?
    Maziarz RT
    Curr Opin Hematol; 2008 Mar; 15(2):127-33. PubMed ID: 18300759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy of chronic myeloid leukemia].
    Rák K
    Orv Hetil; 2003 Mar; 144(9):405-12. PubMed ID: 12688234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiologic burden of chronic myelogenous leukemia.
    Redaelli A; Bell C; Casagrande J; Stephens J; Botteman M; Laskin B; Pashos C
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):85-96. PubMed ID: 14748660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-Line management of CML: a state of the art review.
    Hochhaus A
    J Natl Compr Canc Netw; 2008 Mar; 6 Suppl 2():S1-S10. PubMed ID: 18397676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imatinib therapy for patients with chronic myelogenous leukemia].
    Usui N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):297-303. PubMed ID: 15791812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of chronic myeloid leukaemia (CML).
    Rohrbacher M; Hasford J
    Best Pract Res Clin Haematol; 2009 Sep; 22(3):295-302. PubMed ID: 19959081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
    Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
    Kujawski LA; Talpaz M
    Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Radich JP; Olavarria E; Apperley JF
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):685-702, x. PubMed ID: 15271400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
    Usui N
    Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myelogenous leukaemia: recent progress in biology and therapeutic strategies].
    Turhan AG
    Bull Cancer; 2005 Jan; 92(1):75-82. PubMed ID: 15689327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic myelogenous leukemia following therapy for pineal germinoma].
    Noda M; Shoda T; Takimoto Y; Okita H
    Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for chronic myeloid leukemia.
    Barrett J
    Semin Hematol; 2003 Jan; 40(1):59-71. PubMed ID: 12563612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic myeloid leukemia in the 21st century: biology and treatment].
    Chávez-González MA; Ayala-Sánchez M; Mayani H
    Rev Invest Clin; 2009; 61(3):221-32. PubMed ID: 19736811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation.
    Huang Q; Wu Y; Snyder DS; Chang KL; Slovak ML; Gaal KK; Palmer JM; Weiss LM
    Am J Clin Pathol; 2007 Oct; 128(4):565-70. PubMed ID: 17875506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.